Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

AstraZeneca puts Crestor head-to-head with Lipitor

January 17, 2008 Research and Development

AstraZeneca's Crestor will go head-to-head with Pfizer's mega-brand Lipitor in a global trial assessing the two statins in cardiovascular disease. …
News

Pfizer boosts pipeline with biotech tissue deal

January 16, 2008 Research and Development

Pfizer will partner with German biopharmaceutical company Scil Technology to develop and commercialise a new early-stage biotech treatment for cartilage …
News

Cancer Research invests

January 15, 2008 Research and Development

Cancer Research UK is investing ten million pounds in drug discovery projects at four UK universities. Project leaders at Imperial …
News

Latest news from Datamonitor

January 15, 2008 Research and Development

Competitive obtains license rights for breast cancer testCompetitive Technologies has signed a license and commercialization agreement for rights to the …
News

Animal toxicity test set to be scrapped

January 9, 2008 Research and Development

The pharmaceutical industry has made a major reduction in the number of rodents used in pre-clinical drug testing after an …
News

The Pharmafocus Interview: John Patterson

December 19, 2007 Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations

John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …
Feature

Cervarix US approval delayed

December 19, 2007 Research and Development, Sales and Marketing

GlaxoSmithKline's cervical cancer vaccine Cervarix has suffered a setback in the US, where regulators have refused to approve it until …
News

Latest news from Datamonitor

December 18, 2007 Research and Development

BioMS's multiple sclerosis trial receives positive review from DSMBThe Data Safety Monitoring Board has reviewed data from BioMS Medical's ongoing …
News

Eisai signs $3.9bn biotech deal

December 14, 2007 Research and Development, Sales and Marketing Eisai

Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …
News

GSK boosts portfolio in cancer and anti-infectives

December 14, 2007 Research and Development

GSK has secured two new early-stage biotech licensing deals to boost its product pipeline.The UK-based group unveiled one partnership with …
News

Get ready for inspection

December 13, 2007 Research and Development MHRA, inspection, reg affairs

No one looks forward to receiving a letter from the MHRA (Medicines and Healthcare products Regulatory Agency) inspectorate announcing their …
Feature

Latest news from Datamonitor

December 10, 2007 Research and Development

Adventrx completes enrolment for breast cancer trialAdventrx Pharmaceuticals has completed patient enrolment in its Phase II clinical trial of CoFactor …
News

Safety first

December 10, 2007 Research and Development, Sales and Marketing clinical trials, drug development, drug safety

There is a tide of change in drug safety within the pharmaceutical industry.  Internal and external forces are pushing drug …
Feature

Sanofi and Regeneron sign antibody deal

November 30, 2007 Research and Development

Sanofi-Aventis has increased its stake in Regeneron and will collaborate with the US biotech company on new antibody research.The companies …
News

Latest news from Datamonitor

November 29, 2007 Research and Development

Medivir to initiate Phase IIa study of hepatitis CMedivir has announced that a Phase IIa study for its investigational hepatitis …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026